Fully Coated, Removable, Self-expanding Oesophageal Stents for Preventing Strictures Following Complete Barretts Excision.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate whether preventative placement of a removable oesophageal stent reduces the rate of scar tissue, or stricture formation after removing the precancerous or early cancerous Barrett's mucosa by Endoscopic Mucosal Resection (EMR). The stent will be placed 10-14 days after initial EMR. The stent will then be removed 8 weeks later by repeat Endoscopy. Patients will be followed up weekly following insertion of the oesophageal stent.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Versus Late Endoscopic Stenting for Refractory Benign Esophageal Strictures

NCT06991049

Refractory Benign Esophageal Strictures

RECRUITING NA

Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures

NCT01661686

Esophageal Cancer Esophageal Stenosis

COMPLETED NA

Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment

NCT02751333

Esophageal Strictures Esophageal Leak Esophageal Perforation +3 more

WITHDRAWN PHASE2

Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures

NCT01221311

Common Bile Duct Stricture

COMPLETED NA

A Trial of Esophageal and Gastric Stenting for Leak or Perforation

NCT01107249

Esophageal or Gastric Perforations Esophageal or Gastric Leaks

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constriction, Pathological

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oesophageal Stents

Patients enrolled will receive a fully coated, removable, self-expanding oesophageal stent.

Group Type EXPERIMENTAL

Fully coated, removable , self-expanding oesophageal stent

Intervention Type DEVICE

Insertion of the fully coated, removable, self-expanding oesophageal stent for the prevention of oesophageal strictures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.